Arkolith/Insider Trading/REPL/Form 4

Xynos Konstantinos

Chief Medical OfficerReplimune Group, Inc. (REPL) · full profile →Form 4 · filed Jun 10, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$119K
Net Open-Market Flow
-$119K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 7, 2024Sell(S)16K$7.50$119K117K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-070108) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML